[HTML][HTML] Mesenchymal stem cells and management of COVID-19 pneumonia

SM Metcalfe - Medicine in drug discovery, 2020 - Elsevier
Abstract Human coronavirus, hCoV-19, is highly pathogenic with severe pneumonia
associated with rapid virus replication. Arising in Wuhan China December 2019, the current …

Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives

W Yao, L Shi, Y Zhang, H Dong, Y Zhang - Stem Cell Research & Therapy, 2022 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread into more than 200 countries …

Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19

S Yasamineh, HG Kalajahi, P Yasamineh… - Stem Cell Research & …, 2022 - Springer
The SARS-COV-2 virus has infected the world at a very high rate by causing COVID-19
disease. Nearly 507 million individuals have been infected with this virus, with …

[HTML][HTML] Mesenchymal stem cell treatment for COVID-19

R Xu, Z Feng, FS Wang - EBioMedicine, 2022 - thelancet.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a
global pandemic since late 2019 that resulted in more than 360 million population infection …

Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial

L Shi, X Yuan, W Yao, S Wang, C Zhang, B Zhang… - …, 2022 - thelancet.com
Background The long-term consequences of human umbilical cord-derived mesenchymal
stem cell (UC-MSC) treatment for COVID-19 patients are yet to be reported. This study …

[HTML][HTML] Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)-induced pneumonia

AK Shetty - Aging and disease, 2020 - ncbi.nlm.nih.gov
A new study published by the journal Aging & Disease reported that intravenous
administration of clinical-grade human mesenchymal stem cells (MSCs) into patients with …

Mesenchymal stem cell therapy for severe COVID-19

L Shi, L Wang, R Xu, C Zhang, Y Xie, K Liu… - Signal transduction and …, 2021 - nature.com
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has placed a global public burden on health …

Mesenchymal stem cells as a potential therapy for COVID-19

S Liu, D Peng, H Qiu, K Yang, Z Fu, L Zou - Stem cell research & therapy, 2020 - Springer
The outbreak of 2019 novel coronavirus disease (COVID-19) worldwide is becoming rapidly
a major concern. The number of severe cases has increased dramatically worldwide, while …

Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action

S Sadeghi, S Soudi, A Shafiee, SM Hashemi - Life sciences, 2020 - Elsevier
The outbreak of COVID-19 in December 2019, has become an urgent and serious public
health emergency. At present, there is no effective treatment or vaccine for COVID-19 …

The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm

M Kavianpour, M Saleh, J Verdi - Stem Cell Research & Therapy, 2020 - Springer
The outbreak of coronavirus disease 2019 (COVID-19) pandemic is quickly spreading all
over the world. This virus, which is called SARS-CoV-2, has infected tens of thousands of …